Immunotherapy for tuberculosis: current strategies and future directions
REVIEW|Updated:2025-12-04
|
Immunotherapy for tuberculosis: current strategies and future directions
“Immunotherapy for tuberculosis, a global health threat, has made significant progress. Experts have developed cell therapy and immune checkpoint inhibitors to restore host immunity and combat TB, offering new treatment options. However, comprehensive evaluation of drug safety and treatment duration is needed before clinical application.”
Military Medical ResearchVol. 12, (2025)
Affiliations:
1.Department of Laboratory Medicine/Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu 610041, China
2.Sichuan Clinical Research Center for Laboratory Medicine, Chengdu 610041, China
3.West China School of Medicine, Sichuan University, Chengdu 610041, China
4.Department of Division of Thyroid and Parathyroid SurgeryWest China Hospital, Sichuan University, Chengdu 610041, China
5.Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
Meng-Yuan Lyu, Hong-Li Lai, Hao-Ran Peng, et al. Immunotherapy for tuberculosis: current strategies and future directions[J/OL]. Military Medical Research, 2025, 12.
DOI:
Meng-Yuan Lyu, Hong-Li Lai, Hao-Ran Peng, et al. Immunotherapy for tuberculosis: current strategies and future directions[J/OL]. Military Medical Research, 2025, 12. DOI: 10.1186/s40779-025-00655-7.
Immunotherapy for tuberculosis: current strategies and future directions
Ultrasound initiated tumor catalytic PANoptosis by mesoporous piezoelectric nanocatalysts
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
Metal-based nanomedicines for cancer theranostics
From immunology to artificial intelligence: revolu-tionizing latent tuberculosis infection diagnosis with machine learning
Dynamic Stress Analysis on Speed-increase Subgrade of Existing Railway
Related Author
Jian-Lin Shi
Xuan-Shou Xu
Wei-Wei Ren
Heng Zhang
Dong-Liang Huo
Qi Lyu
Mei-Xiao Zhan
Hui-Xiong Xu
Related Institution
Shanghai Institute of Ceramics, Chinese Acad-emy of Sciences, Research Unit of Nanocatalytic Medicine in Specific Therapy for Serious Disease, Chinese Academy of Medicine Science (2021RU)
Department of Ultrasound, Zhongshan Hospital, Institute of Ultrasound in Medicine and Engineering, Fudan University
Department of Ultrasound, Zhuhai People’s Hospital (the Affiliated Hospital of Beijing Institute of Technology, Zhuhai Clinical Medical College of Jinan University)
Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, the Institute for Biomedical Engineering and Nano Science School of Medicine, Tongji University School of Medicine
Department of General SurgeryInstitute of Precision Diagnosis and Treatment of Digestive System Tumors and Guangdong Provincial Key Laboratory of Chinese Medicine Ingredients and Gut Microbiomics, Carson International Cancer Center, Shenzhen University General Hospital, Shenzhen University